No abstract

Forty-five years after the Apollo and Luna missions returned the lunar samples, China's Chang’E-5 (CE-5) mission collected new samples from the mid-latitude region in the northeastern Oceanus Procellarum of the Moon. Our study shows that 95% of CE-5 lunar soil is distributed in the size of 1.40–9.35 μm, while 95% of the soil by mass is distributed in the size of 4.84–432.27 μm. The bulk density, true density, and specific surface area of CE-5 soil are 1.2387 g/cm3, 3.1952 g/cm3, and 0.56 m2/g, respectively. Fragments from CE-5 regolith are classified into igneous clasts (mostly basalt), agglutinate, and glass. A few breccias were also found. The minerals and compositions of CE-5 soils are consistent with mare basalts and can be classified as low-Ti/low-Al/low-K type with lower rare earth element (REE) contents than materials rich in potassium, rare earth element, and phosphorus (KREEP). CE-5 soils have high FeO and low Mg index, which could represent a new class of basalt.

By using 7 years optical auroral observations obtained at Yellow River Station (magnetic latitude 76.24°N) at Ny-Alesund, Svalbard, we performed the first extensive survey for the dayside diffuse auroras (DDAs) and acquired observational results as follows.(1) The DDAs can be classified into two broad categories, i.e., unstructured and structured DDAs. The unstructured DDAs are mainly distributed in morning and afternoon, but the structured DDAs predominantly occurred around the magnetic local noon (MLN). (2) The unstructured DDAs observed in morning and afternoon present obviously different properties. The afternoon ones are much stable and seldom show pulsating property. (3) The DDAs are more easily observed under geomagnetically quiet times. (4) The structured DDAs mainly show patchy, stripy, and irregular forms and are often pulsating and drifting. The drifting directions are mostly westward (with speed ~5 km/s), but there are cases showing eastward or poleward drifting. ( 5) The stripy DDAs are exclusively observed near the MLN and, most importantly, their alignments are confirmed to be consistent with the direction of ionospheric convection near the MLN. (6) A new auroral form, called throat aurora, is found to be developed from the stripy DDAs. Based on the observational results and previous studies, we proposed our explanations to the DDAs. We suggest that the unstructured DDAs observed in the morning are extensions of the nightside diffuse aurora to the dayside, but that observed in the afternoon are predominantly caused by proton precipitations. The structured DDAs occurred near the MLN are caused by interactions of cold plasma structures, which are supposed to be originated from the ionospheric outflows or plasmaspheric drainage plumes, with hot electrons from the plasma sheet. We suppose that the cold plasma structures for producing the patchy DDAs are in lumpy and are more likely from the plasmaspheric drainage plumes. The cold plasma structure for producing the stripy DDAs should be in wedge like and is generated by conveying the cold plasmas from lower L-shell toward higher L-shell with magnetospheric convection, and that for producing the irregular DDAs is resulted from deforming the wedge-like structure by disturbance. The throat aurora is supposed to be projection of a newly opened flux of reconnection. In addition, we also found that structured DDAs correspond to structured electron precipitations in the ionosphere, which implies that the cold plasma structures in the magnetosphere are magnetically mapped to the ionosphere and act as a duct for producing the structured DDAs. We argue that we have presented some new observational results about DDA in this paper, which will be useful for fully understanding the DDAs.

PurposeWe evaluated the prognostic value of total lesion glycolysis (TLG) measured in baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP).MethodsA total of 91 patients with newly diagnosed DLBCL underwent 18F-FDG PET/CT scans before R-CHOP therapy. Metabolic tumor volume (MTV) was measured with the marginal threshold of normal liver mean standard uptake value (SUVmean) plus 3 standard deviations (SD). TLG was the sum of the products of MTV and SUVmean in all measured lesions. The predictive value was estimated by Log-rank test and Cox-regression analysis.ResultsMedian follow-up was 30 months (range, 5-124 months). The 5-year estimated progression-free survival (PFS) of the low and high TLG group were 83% and 34%, respectively (p<0.001). The 5-year overall survival (OS) of the same groups were 92% and 67%, respectively (p<0.001). Patients with high TLG level were more likely to relapse than those with low TLG level even though they had got complete or partial remission in R-CHOP therapy (40% versus 9%, p=0.012). Multivariate analysis revealed TLG was the only independent predictor for PFS (Hazard ratio=5.211, 95% confidence interval=2.210-12.288, p<0.001) and OS (Hazard ratio=9.136, 95% confidence interval=1.829-45.644, p=0.002). Other factors including MTV, National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI) and Ann Arbor Stage were not independently predictive for survivals.ConclusionBaseline TLG is the only independent predictor for PFS and OS in DLBCL patients treated with R-CHOP therapy.

BackgroundThe prognostic significance of Epstein-Barr virus (EBV) infection in gastric cancer (GC) remains unclear. Recently, a number of studies have investigated the association between EBV infection and the prognosis of GC with controversial results. We therefore conducted a meta-analysis to assess its prognostic significance.MethodsPubMed and EMBASE were searched for studies up to October 1, 2014. We investigated the association between EBV infection with survival in patients with GC. The pooled hazard ratio (HR) and its 95 % confidence interval (CI) were calculated to evaluate risk.ResultsA final analysis of 8,336 patients with GC from 24 studies was performed. Our analysis results indicated that the pooled HR was 0.67 (95 % CI: 0.55–0.79; Z = 11.18, P < 0.001). Subgroup analyses stratified by region revealed that the protective role of EBV infection only remained in the Asian population (HR: 0.62, 95 % CI: 0.48–0.75; P < 0.001). When stratified by study quality and statistical methodology, the protective role could also be identified in high quality studies (HR: 0.67, 95 % CI: 0.55–0.79) and in univariate analysis studies (HR: 0.62, 95 % CI: 0.50–0.74). There was no evidence of significant heterogeneity and publication bias.ConclusionsThe presence of EBV has a favorable impact on GC patient’s survival, especially in an Asian population. Future updated studies, especially large-scale randomized controlled studies stratified by region, are warranted as validation studies.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-015-1813-9) contains supplementary material, which is available to authorized users.

No abstract

Background Research into drug hypersensitivity associated with the expression of specific HLA alleles has focussed on the interaction between parent drug and the HLA with no attention given to reactive metabolites. For this reason, we have studied HLA‐B*13:01‐linked dapsone hypersensitivity to (a) explore whether the parent drug and/or nitroso metabolite activate T cells and (b) determine whether HLA‐B*13:01 is involved in the response. Methods Peripheral blood mononuclear cells (PBMC) from six patients were cultured with dapsone and nitroso dapsone, and proliferative responses and IFN‐γ release were measured. Dapsone‐ and nitroso dapsone‐specific T‐cell clones were generated and phenotype, function, HLA allele restriction, and cross‐reactivity assessed. Dapsone intermediates were characterized by mass spectrometry. Results Peripheral blood mononuclear cells from six patients and cloned T cells proliferated and secreted Th1/2/22 cytokines when stimulated with dapsone (clones: n = 395; 80% CD4+ CXCR3hiCCR4hi, 20% CD8+CXCR3hiCCR4hiCCR6hiCCR9hiCCR10hi) and nitroso dapsone (clones: n = 399; 78% CD4+, 22% CD8+ with same chemokine receptor profile). CD4+ and CD8+ clones were HLA class II and class I restricted, respectively, and displayed three patterns of reactivity: compound specific, weakly cross‐reactive, and strongly cross‐reactive. Nitroso dapsone formed dimers in culture and was reduced to dapsone, providing a rationale for the cross‐reactivity. T‐cell responses to nitroso dapsone were dependent on the formation of a cysteine‐modified protein adduct, while dapsone interacted in a labile manner with antigen‐presenting cells. CD8+ clones displayed an HLA‐B*13:01‐restricted pattern of activation. Conclusion These studies describe the phenotype and function of dapsone‐ and nitroso dapsone‐responsive CD4+ and CD8+ T cells from hypersensitive patients. Discovery of HLA‐B*13:01‐restricted CD8+ T‐cell responses indicates that drugs and their reactive metabolites participate in HLA allele‐linked forms of hypersensitivity.

18 F-FDG PET has been widely used in the management of malignant tumors. Lactate dehydrogenase A (LDHA) plays an important role in the development, invasion, and metastasis of malignancies. However, the relationship between 18 F-FDG accumulation and LDHA expression has not been investigated. Methods: Retrospective analysis was conducted for 51 patients with lung adenocarcinomas who underwent 18 F-FDG PET. The relationship between maximum standardized uptake value and the expression of LDHA, glucose transporter 1 (GLUT1), and hexokinase 2 (HK2) were examined. RNA interference was used to analyze the role of LDHA in tumor metabolism and growth in A549 cells. The AKT, also known as protein kinase B, pathway was also investigated to evaluate the molecular mechanisms of the relationship between LDHA expression and 18 F-FDG uptake. Results: Maximum standardized uptake value was significantly higher in the LDHA high-expression group than the LDHA low-expression group (P 5 0.018). GLUT1 expression in lung adenocarcinomas was positively correlated with 18 F-FDG accumulation and LDHA expression whereas HK2 expression was not. Knockdown of LDHA led to a significant decrease in GLUT1 expression, 18 F-FDG uptake, and cell proliferation. The activated form of AKT was also decreased after LDHA knockdown. Conclusion: LDHA increases 18 F-FDG accumulation into non-small cell lung cancer, possibly by upregulation of GLUT1 expression but not HK2 expression. LDHA may modulate 18 F-FDG uptake in lung adenocarcinomas via the AKT-GLUT1 pathway. These results indicate that 18 F-FDG PET/CT may predict LDHA expression levels and response to anti-LDHA therapy in lung adenocarcinomas.